| DIRECT COMPETITOR COMPARISON | |
| NGNM.OB | LH | MYGN | ORCH | Industry | | Market Cap: | 48.33M | 7.88B | 2.55B | 53.34M | 73.82M | | Employees: | 114 | 28,000 | 869 | 427 | 410 | | Qtrly Rev Growth (yoy): | 44.50% | 4.40% | 21.70% | -1.30% | 13.50% | | Revenue (ttm): | 27.59M | 4.65B | 341.68M | 56.30M | 141.20M | | Gross Margin (ttm): | 53.16% | 41.84% | 81.34% | 31.73% | 48.92% | | EBITDA (ttm): | 256.47K | 1.11B | 141.76M | 568.00K | 8.84M | | Oper Margins (ttm): | -2.85% | 20.38% | 38.86% | -6.05% | 6.81% | | Net Income (ttm): | -1.71M | 518.70M | 142.16M | -1.93M | N/A | | EPS (ttm): | -0.051 | 4.771 | 1.013 | -0.064 | N/A | | P/E (ttm): | N/A | 15.55 | 26.16 | N/A | 23.30 | | PEG (5 yr expected): | N/A | 1.21 | 0.86 | N/A | 1.41 | | P/S (ttm): | 2.05 | 1.69 | 7.58 | 0.95 | 1.84 |
|
| LH = Laboratory Corp. of America Holdings | | MYGN = Myriad Genetics Inc. | | ORCH = Orchid Cellmark Inc. | | Industry = Medical Laboratories & Research | |
| NEWS ON DIRECT COMPETITORS | |
| • | LH | | LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Change in Directors or Principal Officers
Wed 5:01pm -
EDGAR Online | | • | MYGN | | Myriad Genetics Partners With Mammography Reporting Systems to Increase Identification of High Risk Breast Cancer Patients
Wed 4:05pm -
GlobeNewswire | | • | LH | | [video] Stocks Under $10: 2 New Potential Buys
Wed 10:08am -
at TheStreet.com | | • | LH | | [video] Stocks Under $10: Two New Potential Buys
Wed 10:08am -
at TheStreet.com | | • | LH | | LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Regulation FD Disclosure
Tue, Jan 5 -
EDGAR Online | | • | LH | | Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
Tue, Jan 5 -
Business Wire | | • | MYGN | | UnitedHealth, Ford, Vale: Options Update
Wed, Dec 30 -
at TheStreet.com | | • | MYGN | | Myriad Genetics: Starting to Outperform
Wed, Dec 30 -
at Seeking Alpha | | • | MYGN | | Restarting Myriad Genetics
Thu, Dec 24 -
at Seeking Alpha | | • | MYGN | | Which Is the Best Bet: Biogen, Cepheid, or Myriad?
Wed, Dec 23 -
at Motley Fool | | • | MYGN | | Stocks Worth Waiting For
Tue, Dec 22 -
at Motley Fool | | • | MYGN | | UPDATE - Myriad Pharma to buy Javelin Pharma for $96 mln
Fri, Dec 18 -
at Reuters | | • | ORCH | | ORCHID CELLMARK INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Mon, Dec 14 -
EDGAR Online | | • | ORCH | | U.K. Police Force Veteran, Dr. James M. Hart, to Join Orchid Cellmark Board of Directors
Mon, Dec 14 -
GlobeNewswire | | • | ORCH | | ORCHID CELLMARK INC Financials
Wed, Nov 4 -
EDGAR Online Financials | | • | ORCH | | ORCHID CELLMARK INC Files SEC form 10-Q, Quarterly Report
Fri, Oct 30 -
EDGAR Online | | • | ORCH | | Orchid Cellmark to Present to the Harvard Investors Group
Thu, Oct 29 -
GlobeNewswire | | | All Headlines for these symbols... |
|
|
|
0.31% Nasdaq 
0.05%
Competitors
